Choosing the Right Partner for Extractables and Leachables Testing in the United States

Introduction

In the pharmaceutical and medical device industries, ensuring the safety and efficacy of products is paramount. One critical aspect of this process is extractables and leachables (E&L) testing, which identifies potentially harmful substances that could migrate from packaging or delivery systems into the product. For companies operating in the United States, selecting the right partner for E&L testing is a pivotal decision that impacts compliance, product safety, and market success.

---

Understanding Extractables and Leachables

What Are Extractables?

Extractables are chemical compounds that can be extracted from a material, such as a container or device, under aggressive laboratory conditions. These compounds may include:

• Organic additives
• Inorganic fillers
• Residual solvents
• By-products of polymer degradation

What Are Leachables?

Leachables are a subset of extractables that migrate into the product under normal usage conditions. These compounds can interact with the product, potentially compromising its safety and efficacy.

---

Importance of E&L Testing

Regulatory Compliance

In the United States, regulatory agencies such as the FDA and USP require rigorous E&L testing for pharmaceutical products, medical devices, and combination products [1]. Compliance with these standards ensures that products are safe for patient use.

Product Integrity and Patient Safety

E&L testing safeguards patient health by identifying toxic substances that could lead to adverse effects. It also ensures product quality, reducing the risk of recalls and liability issues [2].

Market Access

Conducting thorough E&L testing facilitates market access, as it demonstrates compliance with stringent regulatory requirements. This is especially important for products intended for international markets.

---

Choosing the Right Partner for E&L Testing

Key Considerations

1. Technical Expertise

Look for a partner with extensive experience in E&L testing, particularly for your specific product category. Their expertise should cover:

• High-performance liquid chromatography (HPLC)
• Gas chromatography-mass spectrometry (GC-MS)
• Inductively coupled plasma mass spectrometry (ICP-MS)

2. Regulatory Knowledge

Ensure the testing provider is well-versed in U.S. and international regulatory guidelines, including FDA, USP <1663> and <1664>, and ICH Q3D standards.

3. State-of-the-Art Facilities

Advanced analytical techniques and equipment are essential for accurate detection and quantification of extractables and leachables. Verify that the lab uses cutting-edge technologies.

4. Customized Testing Protocols

Every product is unique, and testing protocols should be tailored to meet specific requirements. A good partner will offer flexibility and collaboration.

---

Why ResolveMass Laboratories is Your Ideal Partner

ResolveMass Laboratories Inc. offers comprehensive extractables and leachables testing services in the United States. Our capabilities include:

• Advanced analytical techniques such as HPLC, GC-MS, and ICP-MS
• Expertise in regulatory compliance
• Customized testing protocols to suit client needs

Visit our services page for more details: Custom Polymer Synthesis Services and Analytical Testing Services.

---

The E&L Testing Process

Step 1: Risk Assessment

The process begins with a comprehensive risk assessment to identify materials and potential extractables.

Step 2: Analytical Screening

Techniques such as HPLC, GC-MS, and ICP-MS are employed to screen for extractables under controlled conditions.

Step 3: Simulation Studies

Leachables are identified using simulation studies that replicate real-world product usage conditions.

Step 4: Data Analysis and Reporting

Detailed reports are generated, including risk evaluations and recommendations for mitigation.

---

Challenges in E&L Testing

Complex Materials

Advancements in material science have led to the development of complex polymers and composites, which pose challenges in E&L analysis [3].

Sensitivity and Detection Limits

Modern products require ultra-sensitive detection methods to identify trace levels of harmful compounds.

Regulatory Updates

Staying updated with evolving regulations is critical to ensure ongoing compliance.

---

Future Trends in E&L Testing

Integration of AI and Automation

Artificial intelligence and automation are enhancing the accuracy and efficiency of E&L testing.

Green Chemistry Practices

Sustainable testing methodologies are being adopted to minimize environmental impact [4].

Enhanced Detection Methods

New technologies, such as hybrid mass spectrometry, are improving detection capabilities.

---

Contact ResolveMass Laboratories

Partner with ResolveMass Laboratories for reliable and comprehensive extractables and leachables testing. We combine technical expertise, state-of-the-art facilities, and a commitment to regulatory compliance to deliver accurate and actionable results.

Visit our Contact Us page to learn more or to schedule a consultation.

---

References

1. U.S. Food and Drug Administration. “Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics” FDA Regulatory Documents, 2020. https://www.fda.gov/media/70788/download
2. Final Concept Paper ICH Q3E: Guideline for Extractables and Leachables (E&L) Dated 30 June 2020, https://database.ich.org/sites/default/files/ICH_Q3E_ConceptPaper_2020_0710.pdf
3. USP Plastic Packaging General Chapters: An Overview, D. Jenke, D. Norwood, Packaging, Storage, and Distribution Expert Committee, USP, http://www.usp.org/sites/default/files/usp_pdf/EN/meetings/workshops/stim_article_661_final.pdf
4. USP <1663> ASSESSMENT OF EXTRACTABLES ASSOCIATED WITH PHARMACEUTICAL PACKAGING/DELIVERY SYSTEM http://www.usp.org/sites/default/files/usp_pdf/EN/meetings/workshops/m7126.pdf
5. USP <1664> ASSESSMENT OF DRUG PRODUCT LEACHABLES ASSOCIATED WITH PHARMACEUTICAL PACKAGING/DELIVERY SYSTEMS
   http://www.usp.org/sites/default/files/usp_pdf/EN/meetings/workshops/m7127.pdf